Heart Drug From Nearly-Forgotten Class May Treat Alzheimer’s

(MedPage Today) — TORONTO — Biomarkers pointing to increased risk for Alzheimer’s disease were markedly reduced with the investigational cholesteryl ester transfer protein (CETP) inhibitor obicetrapib relative to placebo in a large phase III…